Microbot Medical (MBOT) Payables (2010 - 2026)

Microbot Medical (MBOT) has reported Payables for 17 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 483.33% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 483.33% YoY), and the FY2025 full-year result was $511000.0, up 209.7% from the prior year.
• Payables improved to $1.1 million in Q1 2026 per MBOT's latest filing, from $511000.0 in the prior quarter.
• Across five years, Payables topped out at $1.1 million in Q1 2026 and bottomed at $96000.0 in Q1 2024.
• Historically, Payables has averaged $316823.5 across 5 years, with a median of $238000.0 in 2023.
• The sharpest annual moves came in 2022 and 2026: Payables slumped 58.42% in 2022, then jumped 483.33% in 2026.
• Over 5 years, Payables stood at $116000.0 in 2022, then jumped by 207.76% to $357000.0 in 2023, then slumped by 53.78% to $165000.0 in 2024, then surged by 209.7% to $511000.0 in 2025, then surged by 112.33% to $1.1 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $1.1 million, $511000.0, and $509000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.